Greedy Insider · Filing
XERS · Sell · Hecht Beth
Hecht Beth (See Remarks) sold 25,000 shares of Xeris Biopharma Holdings, Inc. (XERS) at $10.23, about $256K, on Nov 2, 2026, filed with the SEC on Nov 4, 2026.
Greediness Score 57 · Mixed · high confidence. Describes filing structure, not future returns. Not investment advice.
Primary source: SEC EDGAR · Accession 0001867096-26-000109